Alzheimer s Research & TherapyNeurosciencePeer-reviewed journal article
Stress-Induced Alteration of Small Extracellular Vesicles Drives Amyloid-Beta Sequestration and Exacerbates Alzheimer's Disease Pathogenesis
Sadaqa Zehra, Sanskriti RaiiD, Komal Rani, Saumitra Dey Choudhury, Himanshu Rai, Suchismita Bhowmik, Nitin MohaniD, Anu Gupta, Prasun Chatterjee, Thota Jagadeshwar Reddy, Neerja RaniiD, Gyan Prakash ModiiD, Fredrik Nikolajeff, Saroj KumariD
Abstract
While small extracellular vesicles (sEVs) are implicated in amyloid-beta (A{beta}) trafficking, the mechanisms governing their interaction with A{beta} aggregates and plaque formation remain unresolved. Here, we report a paradigm-shifting discovery: sEVs undergo dynamic structural remodelling in response to stress, enabling selective binding to A{beta} aggregates-a phenomenon absent under normal physiological conditions. Using multimodal stressors, including mechanical (ultrasonication/agitation), physical (hyperthermia), and biological (oxidative damage), we demonstrate that stress-modified sEVs exhibit high-affinity binding to small A{beta} aggregates (SA) through scaffold reorganization, as validated by super-resolution microscopy and quantitative colocalization assays. Crucially, these remodelled sEVs act as potent carriers, enhancing SA internalization by neuronal cells in vitro. Strikingly, in post-mortem Alzheimers disease (AD) brains and APP-PS1 transgenic mice, sEVs were spatially enriched at amyloid plaque margins, suggesting a direct role in A{beta} sequestration and plaque expansion. Consistent with clinical relevance, sEVs isolated from AD patients exhibited an intrinsic SA-binding capacity, recapitulating stress-induced interactions observed experimentally. Our findings reveal that stress-primed sEVs function as pathological chaperones, binding to and internalizing A{beta} aggregates, thereby accelerating plaque nucleation and disease progression. This study provides the first evidence of stress-mediated sEV plasticity as a critical driver of A{beta} pathology, redefining therapeutic strategies targeting extracellular vesicle biology in neurodegenerative disorders. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=95 SRC="FIGDIR/small/655679v2_ufig1.gif" ALT="Figure 1"> View larger version (23K): org.highwire.dtl.DTLVardef@107c76borg.highwire.dtl.DTLVardef@1b56848org.highwire.dtl.DTLVardef@d18636org.highwire.dtl.DTLVardef@1c26db4_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 1
- FWCI
- 2.05
- Field percentile
- top 22%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuropathological and Functional Impact of Astrocyte-Derived Extracellular Vesicles in an Aged Model of Alzheimer's Disease
Bao Quach, Sahar N Salehi, … Charisse N. Winston·Experimental NeurologyPeer-reviewed·Jul 3, 2026
- Amyloid-β 42-carrying extracellular vesicles are associated with neurodegeneration and neuroinflammation in Alzheimer's disease
Lukas Raich, Mirko Könken, … Marcel S. Woo·bioRxiv·Nov 27, 2025
- Enrichment of neurodegenerative microglia signature in brain-derived extracellular vesicles isolated from Alzheimer's disease mouse model
Satoshi Muraoka, Mark P. Jedrychowski, … Tsuneya Ikezu·Journal of Proteome ResearchPeer-reviewed·Feb 3, 2021
- Engineered extracellular vesicles targeting BACE1 reduces amyloid beta plaque formation in a genetic mouse model of Alzheimer Disease
Valerie S. Kalluri, Sara P.Y. Che, … Raghu Kalluri·bioRxiv·Aug 11, 2026
- Molecular and Structural Characterization Reveals Divergent Extracellular Vesicle Profiles Between Wild Type and Alzheimer's Disease Cerebrocortical Organoids
Anthony Balistreri, Natalie Turner, … Jeffery W. Kelly·bioRxiv·May 14, 2026
- Glucocorticoids regulate small extracellular vesicle (sEV) release via activation of nSMase2
Mia R Burke, Clarissa L. Waites·Journal of Cell SciencePeer-reviewed·Apr 15, 2026